Mucopolysaccharidosis (English Wikipedia)

Analysis of information sources in references of the Wikipedia article "Mucopolysaccharidosis" in English language version.

refsWebsite

Global rank English rank

4^th place

4^th place

2web.archive.org

1^st place

1^st place

2^nd place

2^nd place

447^th place

338^th place

1medlineplus.gov

1,581^st place

1,299^th place

6^th place

6^th place

719^th place

636^th place

1semanticscholar.org

11^th place

8^th place

low place

low place

archive.org

Marks DB, Swanson T, Kim SI, Glucksman M (2007). Biochemistry and molecular biology. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins. ISBN 978-0-7817-8624-9.

biomarin.com

"Aldurazyme (laronidase) for MPS I and approved in April 2003". BioMarin. Archived from the original on 1 October 2020. Retrieved 12 June 2015.

doi.org

Nelson J (December 1997). "Incidence of the mucopolysaccharidoses in Northern Ireland". Human Genetics. 101 (3): 355–8. doi:10.1007/s004390050641. PMID 9439667. S2CID 23099247.
Poorthuis BJ, Wevers RA, Kleijer WJ, Groener JE, de Jong JG, van Weely S, et al. (1999). "The frequency of lysosomal storage diseases in The Netherlands". Human Genetics. 105 (1–2): 151–6. doi:10.1007/s004390051078. PMID 10480370.

fda.gov

accessdata.fda.gov

"Naglazyme". Drugs@FDA: FDA-Approved Drugs.
"MEPSEVIITM (vestronidase alfa-vjbk)" (PDF). Highlights of Prescribing Information. U.S. Food and Drug Administration.

medlineplus.gov

"Mucopolysaccharidosis type I: MedlinePlus Genetics". medlineplus.gov. Retrieved 30 January 2023.

medscape.com

emedicine.medscape.com

eMedicine Specialties > Mucopolysaccharidosis Type I Author: Maryam Banikazemi. Updated: Apr 14, 2009

nih.gov

pubmed.ncbi.nlm.nih.gov

Nelson J (December 1997). "Incidence of the mucopolysaccharidoses in Northern Ireland". Human Genetics. 101 (3): 355–8. doi:10.1007/s004390050641. PMID 9439667. S2CID 23099247.
Poorthuis BJ, Wevers RA, Kleijer WJ, Groener JE, de Jong JG, van Weely S, et al. (1999). "The frequency of lysosomal storage diseases in The Netherlands". Human Genetics. 105 (1–2): 151–6. doi:10.1007/s004390051078. PMID 10480370.

ninds.nih.gov

"Mucopolysaccharidoses Face Sheet". National Institute of Neurological Disorders and Stroke. 15 Nov 2017. Archived from the original on 18 August 2016. Retrieved 11 May 2018.

semanticscholar.org

api.semanticscholar.org

Nelson J (December 1997). "Incidence of the mucopolysaccharidoses in Northern Ireland". Human Genetics. 101 (3): 355–8. doi:10.1007/s004390050641. PMID 9439667. S2CID 23099247.

web.archive.org

"Mucopolysaccharidoses Face Sheet". National Institute of Neurological Disorders and Stroke. 15 Nov 2017. Archived from the original on 18 August 2016. Retrieved 11 May 2018.
"Aldurazyme (laronidase) for MPS I and approved in April 2003". BioMarin. Archived from the original on 1 October 2020. Retrieved 12 June 2015.